Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives $10.67 Consensus PT from Brokerages
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) has been given an average rating of “Buy” by the six brokerages that are currently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the stock in […]
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) has been given an average rating of “Buy” by the six brokerages that are currently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the stock in […]
